Literature DB >> 2323826

Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis.

R F Hector1, E Yee, M S Collins.   

Abstract

Mouse models of systemic candidiasis and pulmonary and systemic aspergillosis were established by using DBA/2N mice, which are known to be deficient in the C5 component of complement. In experiments comparing lethality in the respective models in DBA/2N versus outbred CFW mice, results showed that the 50% lethal dose values for the DBA/2N mice were 10- to 1,000-fold lower than those for the outbred mice, depending on the experiment. Additionally, onset of death was somewhat delayed for the DBA/2N mice. In the case of the pulmonary aspergillosis model, administration of cortisone acetate was necessary to ensure lethality after intranasal infection, but only a single dose was necessary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323826      PMCID: PMC258651          DOI: 10.1128/iai.58.5.1476-1478.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Device for inhalation exposure of animals to spores.

Authors:  W R PIGGOTT; C W EMMONS
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

2.  Experimental moniliasis in mice.

Authors:  S M ADRIANO; J SCHWARZ
Journal:  Am J Pathol       Date:  1955 Sep-Oct       Impact factor: 4.307

3.  New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species.

Authors:  V R Scott; R Boehme; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component.

Authors:  F L Lyon; R F Hector; J E Domer
Journal:  J Med Vet Mycol       Date:  1986-10

5.  Itraconazole treatment of murine aspergillosis.

Authors:  J R Graybill; J Ahrens
Journal:  Sabouraudia       Date:  1985-06

6.  Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative.

Authors:  S Jevons; G E Gymer; K W Brammer; D A Cox; M R Leeming
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

7.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

Authors:  A Schaffner; H Douglas; A Braude
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

Authors:  M N Guentzel; C Herrera
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

9.  Immune responses to Candida albicans in genetically distinct mice.

Authors:  R F Hector; J E Domer; E W Carrow
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice.

Authors:  D M Dixon; A Polak; T J Walsh
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

View more
  30 in total

1.  Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo.

Authors:  Joanne M Kingsbury; Alan L Goldstein; John H McCusker
Journal:  Eukaryot Cell       Date:  2006-05

Review 2.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.

Authors:  Rebekah E Wharton; Emily K Stefanov; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

4.  Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins.

Authors:  Rajashri Shende; Sarah Sze Wah Wong; Srikanth Rapole; Rémi Beau; Oumaima Ibrahim-Granet; Michel Monod; Karl-Heinz Gührs; Jayanta Kumar Pal; Jean-Paul Latgé; Taruna Madan; Vishukumar Aimanianda; Arvind Sahu
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 6.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

7.  Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Authors:  Lisa F Shubitz; Sharon M Dial; Robert Perrill; Rachael Casement; John N Galgiani
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

8.  Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis.

Authors:  Hiroshi Kakeya; Yoshitsugu Miyazaki; Hisato Senda; Tsutomu Kobayashi; Masafumi Seki; Koichi Izumikawa; Kazunori Yanagihara; Yoshihiro Yamamoto; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

9.  Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.

Authors:  J K Byron; K V Clemons; J H McCusker; R W Davis; D A Stevens
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.

Authors:  R F Hector; K Schaller
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.